We are live on
!
Find out more
LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$2.63B
1-Year Est. Return
31.52%
This Fund
S&P 500
This Quarter
Est. Return
-13.16%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.18B
AUM Growth
-$93.5M
(-7.3%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
9.6%
Top 10 Holdings %
Top 10 Hldgs %
21.21%
Holding
341
New
184
Increased
50
Reduced
82
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$12.6M |
| 2 |
Manulife Financial
MFC
|
+$7.56M |
| 3 |
Glaukos
GKOS
|
+$7.01M |
| 4 |
Amazon
AMZN
|
+$6.67M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$6.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$11.7M |
| 2 |
UnitedHealth
UNH
|
+$11.3M |
| 3 |
iRhythm Holdings
IRTC
|
+$9.63M |
| 4 |
Halozyme
HALO
|
+$8.33M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$7.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.65% |
| 2 | Financials | 13.97% |
| 3 | Consumer Discretionary | 13.94% |
| 4 | Technology | 8.36% |
| 5 | Industrials | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Williams Companies
WMB
$90.1B
| $282K | 0.02% |
+9,038
| New | +$312K |
|
277
Fortis
FTS
$28.7B
| $280K | 0.02% |
+5,985
| New | +$293K |
|
278
Edison International
EIX
$26.7B
| $276K | 0.02% |
+4,358
| New | +$295K |
|
279
Nutrien
NTR
$32.1B
| $273K | 0.02% |
+3,463
| New | +$336K |
|
280
Old Dominion Freight Line
ODFL
$44.1B
| $273K | 0.02% |
+2,132
| New | +$279K |
|
281
Boston Scientific
BSX
$74.5B
| $269K | 0.02% |
7,221
-3,330
| -32% | -$136K |
|
282
Kroger
KR
$34.3B
| $268K | 0.02% |
+5,667
| New | +$302K |
|
283
Canadian Imperial Bank of Commerce
CM
$110B
| $267K | 0.02% |
+5,548
| New | +$302K |
|
284
T. Rowe Price
TROW
$23.8B
| $264K | 0.02% |
+2,320
| New | +$295K |
|
285
Cencora
COR
$60B
| $263K | 0.02% |
+1,860
| New | +$285K |
|
286
Agilent Technologies
A
$41.9B
| $262K | 0.02% |
+2,204
| New | +$271K |
|
|
EA
287
DELISTED
Electronic Arts
EA
| $261K | 0.02% |
+2,143
| New | +$273K |
|
288
Stryker
SYK
$133B
| $257K | 0.02% |
+1,291
| New | +$303K |
|
289
Ventas
VTR
$45.7B
| $254K | 0.02% |
+4,932
| New | +$276K |
|
290
KLA
KLAC
$272B
| $253K | 0.02% |
+7,930
| New | +$267K |
|
291
Welltower
WELL
$166B
| $252K | 0.02% |
+3,056
| New | +$272K |
|
292
Dow Inc
DOW
$22.1B
| $250K | 0.02% |
+4,845
| New | +$310K |
|
293
Sempra
SRE
$56.2B
| $250K | 0.02% |
+3,322
| New | +$267K |
|
294
American International
AIG
$39.8B
| $245K | 0.02% |
+4,790
| New | +$278K |
|
295
Public Storage
PSA
$60.4B
| $244K | 0.02% |
+781
| New | +$270K |
|
296
CGI
GIB
$15.3B
| $242K | 0.02% |
+3,066
| New | +$247K |
|
297
Otis Worldwide
OTIS
$28.2B
| $232K | 0.02% |
+3,282
| New | +$242K |
|
298
Moderna
MRNA
$25.4B
| $230K | 0.02% |
+1,607
| New | +$230K |
|
299
Ball Corp
BALL
$16.4B
| $229K | 0.02% |
+3,335
| New | +$253K |
|
300
Dell
DELL
$313B
| $229K | 0.02% |
+4,966
| New | +$235K |
|
Similar funds
SI
WWM
ACM
CCM
MG
PCMI
PCIG
MAMU
Lombard Odier Asset Management (Switzerland)'s Q2 2022 Portfolio in Review
As of Q2 2022, Lombard Odier Asset Management (Switzerland) held 341 positions worth $1.18B, down 7.3% from $1.27B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Lombard Odier Asset Management (Switzerland) deployed $113M of net new capital in Q2 2022, opening 184 new positions and adding to 50 existing holdings. Its largest new stake was Glaukos: 147,742 shares worth $6.71M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 57% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was AbbVie, an estimated $11.7M trimmed.
- Lombard Odier Asset Management (Switzerland)'s largest Q2 2022 buy was Glaukos: 147,742 shares worth $6.71M.
- Lombard Odier Asset Management (Switzerland) added most to DexCom in Q2 2022, an estimated $12.6M increase.
- Lombard Odier Asset Management (Switzerland)'s biggest Q2 2022 reduction was AbbVie, cutting an estimated $11.7M.
- Lombard Odier Asset Management (Switzerland) fully exited G1 Therapeutics, Inc. Common Stock in Q2 2022, selling an estimated $4.12M.
- Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 21% of its $1.18B portfolio in Q2 2022.
- Lombard Odier Asset Management (Switzerland) opened 184 new positions and closed 18 in Q2 2022.
- Lombard Odier Asset Management (Switzerland)'s portfolio value fell 7.3% quarter-over-quarter to $1.18B.
Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 15 Aug 2022.